YEVGENIY KHARITON to Humans
This is a "connection" page, showing publications YEVGENIY KHARITON has written about Humans.
Connection Strength
0.187
-
Update on cardiogenic shock: from detection to team management. Curr Opin Cardiol. 2023 03 01; 38(2):108-115.
Score: 0.021
-
Heterogeneity of health status treatment response with sacubitril/valsartan: insights from the CHAMP-HF registry. ESC Heart Fail. 2021 02; 8(1):710-713.
Score: 0.018
-
Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in?Heart?Failure With Reduced Ejection?Fraction. JACC Heart Fail. 2019 11; 7(11):933-941.
Score: 0.017
-
Health Status Benefits of Successful?Chronic Total Occlusion Revascularization Across the Spectrum?of?Left Ventricular Function: Insights From the OPEN-CTO Registry. JACC Cardiovasc Interv. 2018 11 26; 11(22):2276-2283.
Score: 0.016
-
Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease. Clin Cardiol. 2018 Nov; 41(11):1414-1422.
Score: 0.016
-
Health Status Disparities by Sex, Race/Ethnicity,?and Socioeconomic Status in Outpatients With Heart Failure. JACC Heart Fail. 2018 06; 6(6):465-473.
Score: 0.015
-
Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry. Circ Cardiovasc Qual Outcomes. 2018 04; 11(4):e004668.
Score: 0.015
-
Impact of transesophageal echocardiography on management in patients with suspected cardioembolic stroke. Am J Cardiol. 2014 Dec 15; 114(12):1912-6.
Score: 0.012
-
Association Between Change in Ambulatory Pulmonary Artery Pressures and Natriuretic Peptides in Patients with Heart Failure: Results From the EMBRACE-HF Trial. J Card Fail. 2023 09; 29(9):1324-1328.
Score: 0.005
-
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nat Med. 2021 11; 27(11):1954-1960.
Score: 0.005
-
Association Between Change in Ambulatory Hemodynamic Pressures and Symptoms of Heart Failure. Circ Heart Fail. 2021 11; 14(11):e008446.
Score: 0.005
-
Association between sacubitril/valsartan initiation and real-world health status trajectories over 18?months in heart failure with reduced ejection fraction. ESC Heart Fail. 2021 08; 8(4):2670-2678.
Score: 0.005
-
Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE-HF trial. Diabetes Obes Metab. 2021 06; 23(6):1426-1430.
Score: 0.005
-
Systemizing the Evaluation of Acute Heart Failure in the Emergency Department: A Quality Improvement Initiative. Circ Cardiovasc Qual Outcomes. 2020 11; 13(11):e006168.
Score: 0.005
-
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial. Circulation. 2019 10 29; 140(18):1463-1476.
Score: 0.004
-
Association of Changes in Heart?Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF. JACC Heart Fail. 2019 07; 7(7):615-625.
Score: 0.004
-
Target Doses of Heart Failure Medical?Therapy and Blood Pressure: Insights From the CHAMP-HF Registry. JACC Heart Fail. 2019 04; 7(4):350-358.
Score: 0.004
-
Vaccination Trends in Patients With Heart?Failure: Insights From Get With The Guidelines-Heart Failure. JACC Heart Fail. 2018 10; 6(10):844-855.
Score: 0.004
-
Association Between Prompt Defibrillation and Epinephrine Treatment With Long-Term Survival After In-Hospital Cardiac Arrest. Circulation. 2018 05 08; 137(19):2041-2051.
Score: 0.004
-
Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection Fraction: A Secondary Analysis of 2 Randomized Clinical Trials. JAMA Cardiol. 2017 12 01; 2(12):1315-1321.
Score: 0.004
-
Impact of Telemonitoring on Health Status. Circ Cardiovasc Qual Outcomes. 2017 Dec; 10(12).
Score: 0.004